Elevated EGFL6 modulates cell metastasis and growth via AKT pathway in nasopharyngeal carcinoma
- PMID: 30444069
- PMCID: PMC6308048
- DOI: 10.1002/cam4.1883
Elevated EGFL6 modulates cell metastasis and growth via AKT pathway in nasopharyngeal carcinoma
Abstract
Epidermal growth factor-like domain multiple 6 (EGFL6) is a secreted protein, regulates maintenance and metastasis of cancer cells. Nevertheless, how EGFL6 participates in the progression and tumorigenesis of nasopharyngeal carcinoma (NPC) remains unclear. In our study, EGFL6 was detected highly expressed in 20 NPC tissues compared with normal tissues by IHC assay. Then, the level of EGFL6 in NPC serum and NPC cells was explored through enzyme-linked immunosorbent assay and western blot, the results consistent with IHC. More interestingly, EGFL6 accelerated the migration and growth of NPC in vitro assays. Considering the mechanism of migration, NPC cells were cultured with AKT activator, revealing EGFL6 facilitated the progression of NPC via AKT. Moreover, the same effect of EGFL6 in promoting NPC growth was proved in nude mice. Furthermore, heat-shock zebrafish model was established with EGFL6 overexpression. Then, CNE2 cells were injected into the model and cells mass was observed, showing that EGFL6 enhanced the migration and metastasis of NPC. Currently, as the prognosis of NPC is severely affected by distant metastasis, it might be a new therapeutic target toward EGFL6. Taken together, our results suggested that EGFL6 acts as a potential positive regulator in the migration and proliferation of NPC.
Keywords: AKT; EGFL6; growth; metastasis; nasopharyngeal carcinoma.
© 2018 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
Figures
Similar articles
-
Epithelial cell adhesion molecule overexpression regulates epithelial-mesenchymal transition, stemness and metastasis of nasopharyngeal carcinoma cells via the PTEN/AKT/mTOR pathway.Cell Death Dis. 2018 Jan 5;9(1):2. doi: 10.1038/s41419-017-0013-8. Cell Death Dis. 2018. PMID: 29305578 Free PMC article.
-
DOC-2/DAB2 interactive protein regulates proliferation and mobility of nasopharyngeal carcinoma cells by targeting PI3K/Akt pathway.Oncol Rep. 2017 Jul;38(1):317-324. doi: 10.3892/or.2017.5704. Epub 2017 Jun 6. Oncol Rep. 2017. PMID: 28586035
-
Saucerneol attenuates nasopharyngeal carcinoma cells proliferation and metastasis through selectively targeting Grp94.Phytomedicine. 2022 Jul;101:154133. doi: 10.1016/j.phymed.2022.154133. Epub 2022 Apr 26. Phytomedicine. 2022. PMID: 35504052
-
The emerging role of EGFL6 in angiogenesis and tumor progression.Int J Med Sci. 2020 May 25;17(10):1320-1326. doi: 10.7150/ijms.45129. eCollection 2020. Int J Med Sci. 2020. PMID: 32624687 Free PMC article. Review.
-
Nasopharyngeal carcinoma metastasis to the breast.Saudi Med J. 2020 Oct;41(10):1130-1134. doi: 10.15537/smj.2020.10.25420. Saudi Med J. 2020. PMID: 33026055 Free PMC article. Review.
Cited by
-
The Influence of Race/Ethnicity on the Transcriptomic Landscape of Uterine Fibroids.Int J Mol Sci. 2023 Aug 30;24(17):13441. doi: 10.3390/ijms241713441. Int J Mol Sci. 2023. PMID: 37686244 Free PMC article.
-
EGFL6 promotes bone metastasis of lung adenocarcinoma by increasing cancer cell malignancy and bone resorption.Clin Exp Metastasis. 2023 Aug;40(4):357-371. doi: 10.1007/s10585-023-10219-5. Epub 2023 Jun 28. Clin Exp Metastasis. 2023. PMID: 37378837
-
Generation and characterization of humanized affinity-matured EGFL6 antibodies for ovarian cancer therapy.Gynecol Oncol. 2023 Apr;171:49-58. doi: 10.1016/j.ygyno.2023.02.004. Epub 2023 Feb 17. Gynecol Oncol. 2023. PMID: 36804621
-
Progress of EGFL6 in angiogenesis and tumor development.Int J Clin Exp Pathol. 2022 Nov 15;15(11):436-443. eCollection 2022. Int J Clin Exp Pathol. 2022. PMID: 36507067 Free PMC article. Review.
-
Cell Proliferation and Apoptosis-Related Genes Affect the Development of Human Nasopharyngeal Carcinoma Through PI3K/AKT Signaling Pathway.Mol Biotechnol. 2021 Nov;63(11):1081-1091. doi: 10.1007/s12033-021-00357-0. Epub 2021 Jul 8. Mol Biotechnol. 2021. PMID: 34236626
References
-
- Chen YP, Tang LL, Yang Q, et al. Induction chemotherapy plus concurrent chemoradiotherapy in endemic nasopharyngeal carcinoma: individual patient data pooled analysis of four randomized trials. Clin Cancer Res. 2018;24:1824‐1833. - PubMed
-
- Yao JJ, Zhou GQ, Wang YQ, et al. Prognostic values of the integrated model incorporating the volume of metastatic regional cervical lymph node and pretreatment serum Epstein‐Barr virus DNA copy number in predicting distant metastasis in patients with N1 nasopharyngeal carcinoma. Chin J Cancer. 2017;36:98. - PMC - PubMed
-
- Song IJ, Ikram M, Subhan F, et al. Molecular characterization and expression analysis of mouse epidermal growth factor‐like domain 8. Int J Mol Med. 2015;36:541‐550. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
